Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
94579 trials found · Page 135 of 4729
-
Can induced cooling save more brains after In-Hospital cardiac arrest?
Disease control Not yet recruitingThe IH-TTM trial is designed to determine whether survival with a favorable neurological outcome is improved by induced hypothermia at 33°C in comatose critically ill patients admitted after resuscitated in-hospital cardiac arrest (IHCA). Recent evidence suggests that targeted te…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Computer guidance may sharpen liver cancer treatment
Disease control Recruiting nowThe goal of this clinical trial is to learn if the intraoperative use of a computer guidance software can improve the success of liver tumor ablation in adults. The employed software calculates and displays a simulation of the ablation such that the physician can visualize what p…
Phase: NA • Sponsor: NE Scientific INC • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Fat infusion showdown: can a better oil save preemie lungs and brains?
Disease control Recruiting nowThe purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE …
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for Hard-to-Treat cancers: drug combo targets PTEN loss
Disease control Not yet recruitingThis is a single-arm, open-label, multicenter, Phase Ib/II clinical trial of CVL237 tablets in combination with serplulimab injection for the treatment of advanced solid tumors with PTEN loss or low expression
Phase: PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Can a sleep machine stop heart flutters after ablation?
Disease control Not yet recruitingAtrial fibrillation (AF) is one of the most common clinical arrhythmias. Catheter ablation is an effective therapeutic strategy; however, recurrence rates remain substantial, ranging from 20% to 45%. Previous studies have established a strong association between obstructive sleep…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New shot could bring relief to millions with severe eczema
Disease control Not yet recruitingRationale (What is the reason for this study?) Atopic dermatitis (AD) is a condition that makes the skin dry and itchy and is the most common skin condition that causes redness and irritation. The exact cause of AD is unclear but genetic and environmental factors are believed to…
Phase: PHASE3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New hope for advanced penile cancer: drug combo targets tough cases
Disease control Not yet recruitingPenile cancer is a rare malignant tumor of the male genitourinary system, with 95% being squamous cell carcinoma. Due to social factors, delayed diagnosis is common, leading to a high rate of lymph node metastasis (17%-45% at diagnosis), which significantly impairs quality of lif…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New hope for lymphoma patients: Chemo-Free cocktail aims to shrink tumors without harsh side effects
Disease control Not yet recruitingThis is a single-center, phase 2, open-label clinical trial of a novel combination of polatuzumab vedotin, glofitamab, and tafasitamab (TPG) as first-line treatment of patients with diffuse large B cell lymphoma (DLBCL) or high-grade B cell lymphoma (HGBL).
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Brain zaps for depression: new hope for those failed by meds?
Symptom relief Not yet recruitingThis study will evaluate the efficacy and safety of a theta burst stimulation (TBS) protocol of repetitive transcranial magnetic stimulation (rTMS) in adults with treatment-resistant depression. Participants will be randomized to either antidepressant treatment plus active rTMS T…
Phase: NA • Sponsor: Jung-Sun Lee • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
New study tests best way to tackle lung clots: surgery, Low-Dose drugs, or standard care?
Disease control Not yet recruitingThe STRATIFY II trial investigates the efficacy of three different approaches to reducing thrombus burdon in patients with acute intermediate high-risk pulmonary embolism: percutaneous embolectomy (the AlphaVAC(R), AngioDynamics or the Flow Triever® system, INARI medical), Low in…
Phase: PHASE3 • Sponsor: Jesper Kjaergaard • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Gene therapy hope for rare AGU disease enters human trials
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the treatment is a safe, tolerable, and efficacious treatment for adults and children with Aspartylglucosaminuria (AGU).
Phase: PHASE1, PHASE2 • Sponsor: Rare Trait Hope • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Blood test guides throat cancer therapy, aims to boost survival
Disease control Not yet recruitingThe purpose of this study is to assess risk for HPV driven oropharyngeal cancers by using HPV blood tests and clinical features (such as tumor stage and smoking status) to determine appropriate treatment to improve survival outcomes in participants with stage I, II, or III, HPV-a…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Nasal spray may ward off Post-Surgery confusion in seniors
Symptom relief Not yet recruitingThis study aims to determine whether, compared with placebo, the nighttime self-administration of a nasal dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in high-risk patients.
Phase: PHASE2, PHASE3 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Smarter radiation: fewer sessions, fewer side effects for prostate cancer
Disease control Not yet recruitingThis is a single arm trial that is recruiting a total of 50 participants that have been diagnosed with prostate bed (where the prostate was taken out) or regional (surrounding lymph nodes) recurrence of a prostate cancer following surgery. Salvage radiation treatment represents t…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
New drug cocktail shows promise against head and neck cancer
Disease control ENROLLING_BY_INVITATIONA single-arm, single-center clinical trial evaluating efficacy (Phase #)
Phase: PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Could a common antibiotic boost stroke recovery?
Disease control Not yet recruitingThe aim of this study is to assess the efficacy and safety of minocycline in improving functional outcome among patients with acute ischaemic stroke receiving intravenous thrombolysis.
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Ancient herbs meet modern therapy in battle against cancer insomnia
Symptom relief Not yet recruitingStudy Title: A Multicenter, Randomized Controlled Trial of Tiaoshen Anti-cancer Protocol Combined with Cognitive Behavioral Therapy for Insomnia in Improving Sleep and Survival in Ovarian Cancer Patients Purpose: This study aims to evaluate whether a combined therapy of tradition…
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC
-
New hope for blood cancer patients: drug may prevent post-transplant anemia
Disease control Not yet recruitingAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important treatment for hematological malignancies. Poor erythroid engraftment after transplantation is a serious complication, especially in patients with moderate to severe myelofibrosis (MF). Currently, there…
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
AI eye on stomach cancer: new model aims to catch it early
Diagnosis Recruiting nowEarly gastric cancer (EGC) is often difficult to detect accurately during endoscopic examination due to subtle morphological features and variability among endoscopists. Artificial intelligence (AI) has shown promise in improving diagnostic performance; however, most existing mod…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Diagnosis
Last updated May 15, 2026 11:57 UTC
-
Promising new combo targets rare leukemia in early trial
Disease control Not yet recruitingThis is a prospective, open-label, single-arm, two-cohort Phase 2 clinical study designed to evaluate the efficacy and safety of Bcl-2 Inhibitor combined with azacitidine (with blinatumomab added in B/myeloid subtype) in patients with newly diagnosed mixed phenotype acute leukemi…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC